Phase IIa Study of Fenretinide in Superficial Bladder Cancer, Using DNA Flow Cytometry as an Intermediate End Point
Authors: A. Decensi, S. Bruno, M. Costantini, R. Torrisi, A. Curotto, B. Gatteschi, G. Nicolo, A. Polizzi, M. Perloff, W. F. Malone, P. Bruzzi
Journal: JNCI Journal of the National Cancer Institute (1994)

Journal Article Phase IIa Study of Fenretinide in Superficial Bladder Cancer, Using DNA Flow Cytometry as an Intermediate End Point Get access Andrea Decensi, Andrea Decensi Department of Medical Oncology II, National Institute for Cancer ResearchGenoa, Italy Correspondence to : Andrea Decensi, M.D., Servizio di Oncologia Medica II, Istituto Nazionale per la Ricerca sul Cancro, Viale Benedetto XV, 10 – 16132 Genoa, Italy. Search for other works by this author on: Oxford Academic PubMed Google Scholar Silvia Bruno, Silvia Bruno Department of Biophysics, National Institute for Cancer ResearchGenoa, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Massimo Costantini, Massimo Costantini Department of Clinical Epidemiology, National Institute for Cancer ResearchGenoa, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Rosalba Torrisi, Rosalba Torrisi Department of Clinical Epidemiology, National Institute for Cancer ResearchGenoa, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Antonio Curotto, Antonio Curotto Institute of Urology, The University of Genoa Search for other works by this author on: Oxford Academic PubMed Google Scholar Beartice Gatteschi, Beartice Gatteschi Department of Pathology, National Institute for Cancer ResearchGenoa, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Guido Nicolò, Guido Nicolò Department of Pathology, National Institute for Cancer ResearchGenoa, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Anna Polizzi, Anna Polizzi Institute of Ophthalmology, The University of Genoa Search for other works by this author on: Oxford Academic PubMed Google Scholar Majorie Perloff, Majorie Perloff Division of Cancer Prevention and Control, Chemoprevention Branch, National Cancer InstituteBethesda, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar Winfred F. Malone, Winfred F. Malone Division of Cancer Prevention and Control, Chemoprevention Branch, National Cancer InstituteBethesda, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar ... Show more Paolo Bruzzi Paolo Bruzzi Department of Clinical Epidemiology, National Institute for Cancer ResearchGenoa, Italy Correspondence to : Andrea Decensi, M.D., Servizio di Oncologia Medica II, Istituto Nazionale per la Ricerca sul Cancro, Viale Benedetto XV, 10 – 16132 Genoa, Italy. Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 86, Issue 2, 19 January 1994, Pages 138–140, https://doi.org/10.1093/jnci/86.2.138 Published: 19 January 1994 Article history Received: 29 June 1993 Revision received: 18 November 1993 Accepted: 22 November 1993 Published: 19 January 1994